Form 8-K - Current report:
SEC Accession No. 0000310158-22-000015
Filing Date
2022-05-26
Accepted
2022-05-26 16:06:45
Documents
13
Period of Report
2022-05-24
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K mrk-20220524.htm   iXBRL 8-K 74141
  Complete submission text file 0000310158-22-000015.txt   275249

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrk-20220524.xsd EX-101.SCH 3527
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrk-20220524_def.xml EX-101.DEF 16849
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrk-20220524_lab.xml EX-101.LAB 34314
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrk-20220524_pre.xml EX-101.PRE 17651
7 EXTRACTED XBRL INSTANCE DOCUMENT mrk-20220524_htm.xml XML 19070
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06571 | Film No.: 22969969
SIC: 2834 Pharmaceutical Preparations